Apel Daniel Joseph
Arrowhead Pharmaceuticals Inc · Chief Financial Officer
Apel Daniel Joseph is listed in filings as Chief Financial Officer at Arrowhead Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Apr 24, 2026, including sale activity. Recent filings connect the profile to Arrowhead Pharmaceuticals Inc (ARWR). The current snapshot covers public activity from Jan 8, 2026 to Apr 24, 2026. Reported amounts are shown as $627.9K to $224.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||